BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16293800)

  • 1. Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury.
    Liu H; Liu L; Fletcher BS; Visner GA
    Am J Respir Crit Care Med; 2006 Mar; 173(5):566-72. PubMed ID: 16293800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection.
    Laurence JM; Wang C; Zheng M; Cunningham S; Earl J; Tay SS; Allen RD; McCaughan GW; Alexander IE; Bishop GA; Sharland AF
    Liver Transpl; 2009 Feb; 15(2):233-41. PubMed ID: 19177450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression.
    Liu H; Liu L; Liu K; Bizargity P; Hancock WW; Visner GA
    J Immunol; 2009 Jul; 183(2):1022-31. PubMed ID: 19564344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
    Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
    J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis.
    Liu H; Liu L; Fletcher BS; Visner GA
    FASEB J; 2006 Nov; 20(13):2384-6. PubMed ID: 17015408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.
    Lin YC; Chen CL; Nakano T; Goto S; Kao YH; Hsu LW; Lai CY; Jawan B; Cheng YF; Tateno C; Yoshizato K
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e243-50. PubMed ID: 17645734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
    Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
    Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model.
    Liu H; Drew P; Cheng Y; Visner GA
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):852-8. PubMed ID: 16153939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.
    Swanson KA; Zheng Y; Heidler KM; Mizobuchi T; Wilkes DS
    Am J Respir Cell Mol Biol; 2004 Mar; 30(3):311-8. PubMed ID: 12959949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury.
    Liu H; Liu L; Visner GA
    Am J Transplant; 2007 Oct; 7(10):2291-300. PubMed ID: 17711549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy with adenovirus-delivered indoleamine 2,3-dioxygenase improves renal function and morphology following allogeneic kidney transplantation in rat.
    Vavrincova-Yaghi D; Deelman LE; Goor H; Seelen M; Kema IP; Smit-van Oosten A; Zeeuw D; Henning RH; Sandovici M
    J Gene Med; 2011 Jul; 13(7-8):373-81. PubMed ID: 21710661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
    Guillonneau C; Hill M; Hubert FX; Chiffoleau E; Hervé C; Li XL; Heslan M; Usal C; Tesson L; Ménoret S; Saoudi A; Le Mauff B; Josien R; Cuturi MC; Anegon I
    J Clin Invest; 2007 Apr; 117(4):1096-106. PubMed ID: 17404623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible expression of indoleamine 2,3-dioxygenase attenuates acute rejection of tissue-engineered lung allografts in rats.
    Ebrahimi A; Kardar GA; Teimoori-Toolabi L; Ghanbari H; Sadroddiny E
    Gene; 2016 Jan; 576(1 Pt 3):412-20. PubMed ID: 26506443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of indoleamine 2,3-dioxygenase on transplantation immunity].
    Duan X; Cui P; Jiang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):230-3. PubMed ID: 18365624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
    Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection.
    Laurence JM; Wang C; Park ET; Buchanan A; Clouston A; Allen RD; Mccaughan GW; Bishop GA; Sharland AF
    Transplantation; 2008 May; 85(9):1357-61. PubMed ID: 18475196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo.
    Bauer TM; Jiga LP; Chuang JJ; Randazzo M; Opelz G; Terness P
    Transpl Int; 2005 Jan; 18(1):95-100. PubMed ID: 15612990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage.
    Serbecic N; Beutelspacher SC
    Exp Eye Res; 2006 Mar; 82(3):416-26. PubMed ID: 16318852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
    Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
    Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.